Startups
SOMAÍ's proprietary formulations have multiple combinations of cannabinoid concentrations which can be delivered by gel capsules, drops, transdermal patches and other innovative delivery methods. All our products conform to the highest pharmaceutical standards and are produced with the latest technology to ensure consistency. Our team understands cannabis products and patient needs because of our vast experience on the west coast of USA, and we continue to research and develop the most innovative treatments for the World at our newest state-of-art Portuguese manufacturing facility.
Overview
Location
Ireland, Leinster, Dublin
Employees
11-50
Total raised
$8.66M
Founded date
2019
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 12, 2024 | SOMAÍ Pharmaceuticals Introduces UK to The Most Complete Cannabis-Based Product Portfolio Following a Distribution Deal | SOMAÍ Pharmaceuticals Signs Distribution Deal with Grow Pharma for UK’s Most Comprehensive Range of Cannabis-Based Medicines LISBON, PORTUGAL, March 12, 2024 /EINPresswire.com/ -- SOMAÍ Pharmaceuticals ("SOMAÍ"), an EU-GMP Europea... |
| Feb 6, 2024 | SOMAÍ Pharmaceuticals Introducing the U.S. Award-Winning Airo Brand to European and Australian Markets | SOMAÍ Pharmaceuticals to manufacture and distribute Airo Brands’ products in Australian, German, Polish & Swiss medical markets LISBON, PORTUGAL, February 6, 2024 /EINPresswire.com/ -- SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”), an ... |
| Jun 12, 2023 | SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Poland | /EIN News/ -- LISBON, Portugal, June 12, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”) has entered into a two-year supply agreement with a well-respected Polish distributor Cosma Cannabis. Cosma produces medical-gr... |
| Sep 26, 2022 | SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility | LISBON, Portugal, Sept. 26, 2022 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new state-of-the-art pharmaceutical EU-GMP facility in Portugal. SOMAÍ’s phase 1 manufacturing footprint spans 3,800 square ... |
| Somai Pharmaceuticals Ltd | “Home - SOMAÍ Pharmaceuticals” | |
| Somai Pharmaceuticals Ltd | “Next Generation Biotech…” |
Reviews 0
FAQ about SOMAÍ Pharmaceuticals LTD
When was SOMAÍ Pharmaceuticals LTD founded?
SOMAÍ Pharmaceuticals LTD was founded in 2019.
How much funding has SOMAÍ Pharmaceuticals LTD raised?
SOMAÍ Pharmaceuticals LTD has raised $8.66M in total across 1 funding round.
What has the press written about SOMAÍ Pharmaceuticals LTD?
Parsers VC has collected 7 articles mentioning SOMAÍ Pharmaceuticals LTD, among them “SOMAÍ Pharmaceuticals Introduces UK to The Most Complete Cannabis-Based Product Portfolio Following a Distribution Deal” (Mar 12, 2024) and “SOMAÍ Pharmaceuticals Introducing the U.S. Award-Winning Airo Brand to European and Australian Markets” (Feb 6, 2024).
Is SOMAÍ Pharmaceuticals LTD still active?
Yes, SOMAÍ Pharmaceuticals LTD is active; its latest activity on Parsers VC dates from Jan 21, 2025.